Cargando…
An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence
Fecal incontinence (FI) is the involuntary loss of rectal contents through the anal canal. Reports of its prevalence vary from 1–21%. Studies, have demonstrated a positive effect on FI symptoms with injectable bulking agents. This study evaluated the safety and efficacy of NASHA/Dx gel in the treatm...
Autores principales: | Dodi, Giuseppe, Jongen, Johannes, de la Portilla, Fernando, Raval, Manoj, Altomare, Donato F., Lehur, Paul-Antoine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017894/ https://www.ncbi.nlm.nih.gov/pubmed/21234379 http://dx.doi.org/10.1155/2010/467136 |
Ejemplares similares
-
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence
por: Mellgren, A, et al.
Publicado: (2014) -
Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence
por: Sanchez, Jaime E, et al.
Publicado: (2015) -
Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence
por: Franklin, Howard, et al.
Publicado: (2016) -
A short- and long-term follow-up study of intersphincteric NASHA Dx implants for fecal incontinence
por: Ezra, E., et al.
Publicado: (2022) -
A Short Note on Nasha Fever
por: Ganguli, Satkari
Publicado: (1914)